LY2090314

LY2090314, an effective GSK-3α/β inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer.

Price Not Available 5 mg LY2090314 Supplier Page

Catalog Number	T1755
Research Area	Stem Cells\|\|\|PI3K/Akt/mTOR signaling
Molecular Formula	C28H25FN6O3
CAS#	603288-22-8
Purity	99.88%
SMILES	N1(C(=O)N2CCCCC2)Cc2cc(cc3c(C4=C(c5cnc6n5cccc6)C(=O)NC4=O)cn(CC1)c23)F
Size	5 mg
Supplier Page	https://www.targetmol.com/compound/LY2090314
Additional Information	https://www.targetmol.com/datasheet/T1755